(Q43823417)

27 November 2017

Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol (English)

1 reference

27 November 2017

1 reference

1 reference

1

1 reference

27 November 2017

T Tsvetkova

2

1 reference

27 November 2017

E J Eichhorn

series ordinal

3

1 reference

27 November 2017

E M Gilbert

series ordinal

4

1 reference

27 November 2017

M R Bristow

series ordinal

5

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

International Journal of Cardiology

27 November 2017

1 reference

27 November 2017

81

1 reference

27 November 2017

2-3

1 reference

27 November 2017

141-149

1 reference

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Drugs five years later. Dobutamine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Short-term use of intravenous milrinone for heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Hemodynamic and regional blood flow response to milrinone in patients with severe congestive heart failure: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Pharmacology of bipyridine phosphodiesterase III inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Effects of intravenous milrinone on left ventricular function in ischemic and idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Phosphodiesterase III inhibition or adrenoreceptor stimulation: Milrinone as an alternative to dobutamine in the treatment of severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Physiologic Assessment of Milrinone Therapy in Severe Heart Failure Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Cardiovascular effects of milrinone

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900520-4

7 January 2021

10.1016/S0167-5273(01)00520-4

Identifiers

DOI

1 reference

release_cialrldeerhnbmb5xbzp3oktyq

27 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cialrldeerhnbmb5xbzp3oktyq

24 November 2022

mapped directly with Wikidata item

1 reference